Acer Therapeutics Inc. (ACER) Social Stream
ACER THERAPEUTICS INC (ACER) Price Targets From Analysts
Use the tables below to see what analysts covering ACER THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-30 | 2 | $10 | $10 | $10 | $0.848 | 1079.25% |
| 2022-11-21 | 2 | $12 | $10 | $11 | $0.848 | 1197.17% |
| 2023-08-15 | 3 | $12 | $7 | $9.666 | $0.848 | 1039.86% |
| 2023-09-01 | 3 | $7 | $1.5 | $4.25 | $0.848 | 401.18% |
The Trend in the Analyst Price Target
ACER's average price target has moved down $5.75 over the prior 31 months.
Over the past 41 weeks, ACER's average upside potential has been 919.28%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-21 | 2 | 12 | 10.0 | 11.000 | 1.15 | 856.52% |
| 2023-03-20 | 3 | 12 | 7.0 | 9.666 | 0.85 | 1037.18% |
| 2023-05-31 | 3 | 12 | 7.0 | 9.666 | 0.89 | 986.07% |
| 2023-08-15 | 3 | 12 | 7.0 | 9.666 | 0.75 | 1188.8% |
| 2023-09-01 | 3 | 7 | 1.5 | 4.250 | 1.14 | 272.81% |
ACER Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.33 | 1 | 0 | 2 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
ACER's average broker recommendation rating worsened by 1.33 over the prior 14 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, ACER THERAPEUTICS INC's number of analysts covering the stock is higher than 21.2% of them.
- ACER has a higher upside potential (average analyst target price relative to current price) than 475.53% of all US stocks.
- In terms of how ACER THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is greater than 45.91% of that group.
- In the context of Pharmaceutical Products stocks, ACER THERAPEUTICS INC's variance in analysts' estimates is lower than -27.37% of them.
Stocks similar to ACER THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CBAY, SEEL, and CASI.
View All Top Stocks by Price Target
What is the outlook for ACER? Use POWR Ratings for clearer insight into price direction.